HOME >> MEDICINE >> NEWS
Low-dose transdermal estrogen viable short-term treatment for menopausal women

New Haven, CT - April 19, 2004 Low-dose transdermal hormone therapy (HT) remains a viable short-term alternative for women to treat debilitating menopausal symptoms, offer lipid protection and preserve bone health, despite the negative news about oral HT effects from the Women's Health Initiative (WHI), according to a recent review of peer-reviewed medical studies by Mary Jane Minkin, M.D., of Yale University School of Medicine, in the April The Journal of Reproductive Medicine.

"There is a lot to consider when interpreting the WHI results. The fact is that millions of women still suffer from the potentially devastating symptoms of menopause so much so that their quality of life deteriorates. Hormone therapy remains the most effective means to relieve vasomotor symptoms, and certain estrogen formulations and routes of administration that were not studied in WHI offer different health effects that may offer several advantages," said Dr. Minkin, clinical professor in the Department of Obstetrics and Gynecology at Yale.

Unexpected results from the WHI published in June 2002 called into question the safety of all HTs even though investigators only examined oral HTs that used conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA). The researchers cautioned that the WHI results did not necessarily apply to other doses of CEE/MPA, to other types of oral estrogens and progestins, or to other estrogens and progestins delivered by different routes.

"Reproductive healthcare professionals may find it difficult to counsel their patients who suffer from severe menopausal symptoms about appropriate treatment because not all estrogens and progestins are alike. Alternative drugs, doses and delivery systems may exhibit better safety profiles than CEE/MPA formulations, with no loss of efficacy," Dr. Minkin noted.

Transdermal, unlike oral, HT delivery bypasses the liver, permitting the use of estrogen doses that are substant
'"/>

Contact: Lissa Burt
lissa.burt@porternovelli.com
212-601-8238
Porter Novelli
19-Apr-2004


Page: 1 2 3

Related medicine news :

1. Low-dose aspirin and stomach ulcer medications better for heart patients with GI complications
2. Low-dose interferon fails to improve survival in high-risk melanoma patients
3. Low-dose combo no better than aspirin alone in secondary prevention
4. Low-dose oral contraceptives are as protective against ovarian cancer as are older, high-dose pills, find University of Pittsburgh researchers
5. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
6. Subanalysis finds patient-controlled, transdermal pain management system may be comparable
7. Jefferson-led study shows transdermal system as effective as IV pump for post-surgical pain
8. Study shows positive results for novel, patient-controlled transdermal system (PCTS)...
9. Changing chemistry helps explain estrogen threat to the heart
10. Use of estrogen therapy may increase risk for gallbladder disease
11. Decreased sensitivity in the brain to estrogen may help explain menopausal changes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... August 31, 2018 , ... Becker's Healthcare is pleased to ... independent community hospitals as well as facilities affiliated with large health systems. Some ... large cities. The hospitals continue to grow in many communities, opening new departments ...
(Date:8/31/2018)... (PRWEB) , ... August 31, 2018 , ... ... its neuroimaging capabilities with the addition of an MRI Simulator. In the MRI ... scan including sounds. By engaging in this mock scan experience, research participants become ...
(Date:8/31/2018)... HUNTINGDON VALLEY, Pa. (PRWEB) , ... August 31, ... ... equal to those offered by the American Heart Association (AHA) to be responsive ... non-AHA business concerns and purchasing managers may now reap the benefits. Companies like ...
(Date:8/31/2018)... ... August 31, 2018 , ... Rudina Thanasi, a scientifically validated ... energy treated nutraceutical to improve overall immunity and to combat inflammatory and autoimmune ... well as, inflammation. The following data was reported:,     Over ...
(Date:8/31/2018)... ... August 31, 2018 , ... Saturday, September 1st, 2018, Team Fastrax™ will ... State Cyclones season opener game. At 7pm, the Cyclones will kick off against the ... to play, Team Fastrax™ will jump in with their majestic 2,000 sq. ft. American ...
Breaking Medicine News(10 mins):
(Date:9/1/2018)... ... ... Dr. Payam Bostani is now offering Periodontal Osseous (bone) surgeries alongside the general ... twenty years at his Burbank offices. “My goal has always been to offer ... single roof. Periodontics is a crucial specialty because our gums are absolutely central to ...
(Date:8/31/2018)... ... 31, 2018 , ... The Centers for Disease Control and ... expertise in delivering comprehensive wellness engagement solutions, has been selected as the winner ... receive a $40,000 grand prize for its winning proposal, Closing the Loop: Augmenting ...
(Date:8/31/2018)... ... 31, 2018 , ... After a summer of frequently going ... many. , “Prolonged weeks of going barefoot and wearing non-supportive and protective footwear ... Adam Howard, DPM. , “Heel pain and arch pain rank amongst the most ...
Breaking Medicine Technology:
Cached News: